T. Kühn is Vice President for Bruker BioSpin and the head of Bruker BioSpin’s global research and development team. Till is very close to NMR as he is a Chemist by training and received his Ph.D. from the University of Frankfurt in the group Harald Schwalbe on the kinetics of Protein folding studied by NMR. At Bruker, Till has a long history in the development of solutions for NMR-based pharma research – hardware, software and workflows – and he is excited to be able to contribute with this experience to the COVID-19-NMR project.